Alleviation of global symptoms at 4-week follow-up (shown in RD and 95% CI) | ||||||
---|---|---|---|---|---|---|
DLTG | Â | Â | Â | Â | Â | Â |
0.11 (− 0.11, 0.43) | BGD |  |  |  |  |  |
0.11 (− 0.10, 0.43) | 0.02 (− 0.15, 0.26) | TXD |  |  |  |  |
0.12 (− 0.05, 0.35) | 0.02 (− 0.11, 0.19) | 0.01 (− 0.11, 0.17) | MOSA |  |  |  |